8-K
filed April 3, 2026, 7:59 PM ET
ticker DMII
CIK 0002040475
debt
confidence high
sentiment neutral
materiality 0.60
DMIIU enters $1.4M convertible note agreement for de-SPAC financing; issues $300K interim note
Drugs Made In America Acquisition II Corp.
- Total financing commitment of $1.4M; $150K already received, $300K funded on March 30, 2026 as interim convertible note.
- Conversion at 35% discount to post-merger market value at investor's discretion; nine-month maturity.
- Proceeds used for audit, accounting, SEC, Nasdaq fees, legal costs, and transaction preparation.
- Existing sponsor non-performing; investor has right to acquire sponsor interests when legally permitted.
- Exclusivity period of six months to complete de-SPAC transaction.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-039986
- form_type
- 8-K
- ticker
- DMII
- cik
- 0002040475
- company_name
- Drugs Made In America Acquisition II Corp.
- filed_at
- 2026-04-03T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:33.437324+00:00
- generated_at
- 2026-05-15T07:42:58.939353+00:00
- sec_items
- ["1.01", "2.03", "9.01"]
- event_type
- debt
- sentiment
- neutral
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-039986
- json_url
- https://secwatch.observer/filing/0001213900-26-039986.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-039986.md
- text_url
- https://secwatch.observer/filing/0001213900-26-039986.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/2040475/000121390026039986/0001213900-26-039986-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/2040475/000121390026039986/ea0285112-8k_drugs2.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Source-grounded claims
ffe25265d1f383b097c9a48cc37fc17841e15ed7
Drugs Made In America Acquisition II Corp. incurred convertible notes of $300,000 with Alpha Multi Family Office at does not bear interest maturing nine months from the date of issuance.
In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).
SEC 8-K Item 2.03/2.04
confidence 0.9
SEC evidence
502c7ea63c715cfeff70ea23eb2799375e3612d9
Drugs Made In America Acquisition II Corp. entered into Interim Convertible Note with Alpha Multi Family Office valued at $300,000 Interim Convertible Note, convertible with 35% discount (effective 2026-03-30).
on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the " Second Note ").
SEC 8-K Item 1.01/1.02
confidence 0.9
SEC evidence
75d6b4cb9b136192d0bf8b8b15092a28e8053f8c
Drugs Made In America Acquisition II Corp. entered into Definitive Investment and Sponsor Transition Agreement with Alpha Multi Family Office valued at $1,400,000 Convertible Notes Financing (effective 2026-03-24).
Effective March 24, 2026, the Company and the Investor entered into the Definitive Investment and Sponsor Transition Agreement (the " Agreement ") for the Convertible Notes Financing, a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference.
SEC 8-K Item 1.01/1.02
confidence 0.9
SEC evidence
Comparable filings
TCPC
BlackRock TCP Capital closes $535.8M CLO securitization, repays existing debt facilities
BlackRock TCP Capital Corp.
June 1, 2026, 4:50 PM ET
debt
Items 1.01, 1.02, 2.03, 9.01
same fact type: debt_financing, material_agreement
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
This filing
In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).
Comparable filing
Item 1.01. Entry into a Material Definitive Agreement. On May 27, 2026 (the " Closing Date "), BlackRock TCP Capital Corp. (the " Company "), through its subsidiary, completed a $535,780,000 securitization of certain loans held by a subsidiary of the Company (the " CLO Transaction "). On the Closing Date and in connection with the CLO Transaction, BlackRock DLF 2026-C
Filing page
SEC filing
EHC
Encompass Health issues $500M 5.875% notes due 2034; to redeem $400M of 4.500% notes due 2028
Encompass Health Corp
June 1, 2026, 4:26 PM ET
debt
Items 1.01, 2.03, 9.01
same fact type: debt_financing, material_agreement
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
This filing
In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).
Comparable filing
On May 29, 2026, Encompass Health Corporation (the “Company”) completed the issuance and sale of $500 million in aggregate principal amount of its 5.875% Senior Notes due 2034 (the “Notes”), along with the related guarantees of the Notes by certain of the Company’s subsidiaries (the “Guarantees”), in a private offering.
Filing page
SEC filing
VVX
V2X refinances $868.5M term loans with new tranche maturing 2030; SOFR+2% margin
V2X, Inc.
June 1, 2026, 4:10 PM ET
debt
Items 1.01, 2.03, 9.01
same fact type: debt_financing, material_agreement
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
This filing
In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).
Comparable filing
The Amendment provides for, among other things, a new tranche of term loans under the Credit Agreement in an aggregate original principal amount of $868,522,978.38 (the “New Term Loans”), which New Term Loans replace or refinance in full all of the existing term loans outstanding under the Credit Agreement (as in effect immediately prior to the Amendment), as further set forth in the Amendment. The New Term Loans mature on December 6, 2030.
Filing page
SEC filing
EMAT
EMAT secures $100M convertible debenture facility from Yorkville; first $20M tranche issued
Evolution Metals & Technologies Corp.
May 11, 2026, 7:59 PM ET
debt
Items 1.01, 2.03, 3.02, 7.01, 9.01
same fact type: debt_financing, material_agreement
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
This filing
In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).
Comparable filing
The first Convertible Debenture (the “First Debenture”) in the principal amount of $20,000,000 was issued on May 7, 2026.
Filing page
SEC filing
AZZ
AZZ refinances revolver; maturity extended to 2029, margins cut 50 bps
AZZ INC
May 8, 2026, 7:59 PM ET
debt
Items 1.01, 2.03, 9.01
same fact type: debt_financing, material_agreement
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
This filing
In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).
Comparable filing
The Seventh Amendment (i) terminated the Initial Revolving Credit Commitments and simultaneously replaced them in their entirety with Extended Revolving Credit Commitments having a Maturity Date of May 7, 2029, (ii) decreased the interest rate margin applicable to the Revolving Credit Loans from margins ranging from 175 basis points to 275 basis points (subject to leverage ratio step-downs) to margins ranging from 125 basis points to 225 basis points (subject to leverage ratio step-downs)
Filing page
SEC filing
ILPT
ILPT Mountain JV closes $1.62B loan at 5.71% fixed, repays $1.6B existing debt
Industrial Logistics Properties Trust
May 8, 2026, 7:59 PM ET
debt
Items 1.01, 1.02, 2.03, 9.01
same fact type: debt_financing, material_agreement
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
This filing
In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).
Comparable filing
Stanley Bank, N.A., Bank of America, N.A., Bank of Montreal and UBS AG New York Branch, or collectively,
the lenders, pursuant to which Mountain JV obtained, in aggregate, a $1.62 billion loan secured
by 90 of its properties, or the Loan . Also on May 8, 2026, we entered into a guaranty in favor of the lenders, pursuant to which
we guaranteed certain limited
Filing page
SEC filing
PGIM
PGIM Private Credit Fund enters $100M credit facility with $500M accordion option
PGIM Private Credit Fund
May 8, 2026, 7:59 PM ET
debt
Items 1.01, 2.03, 9.01
same fact type: debt_financing, material_agreement
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
This filing
In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).
Comparable filing
Repo Rate Average; and for Australian‐dollar advances, Bank Bill Swap Rate), in each case subject to a 0.25% floor. The initial facility amount of the Credit Facility is $100 million, with an accordion feature that permits increases, with the consent of the facility agent and the lenders, up to an aggregate commitment of $500 million. The Credit Facility has
Filing page
SEC filing
LYV
Live Nation VenueCo closes €610M secured notes issuance backed by 4 venues
Live Nation Entertainment, Inc.
May 8, 2026, 7:59 PM ET
debt
Items 1.01, 2.03, 9.01
same fact type: debt_financing, material_agreement
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
This filing
In addition, on March 30, 2026, the Company and the Investor entered into an Interim Convertible Note in the amount of $300,000 (the “ Second Note ”).
Comparable filing
On May 8, 2026, Live Nation VenueCo, LLC (“VenueCo”), a bankruptcy-remote, special purpose vehicle owned by certain bankruptcy-remote, special purpose entities (the “Participants”), which are indirect subsidiaries of Live Nation Entertainment, Inc. (the “Company”), closed its previously announced issuance of €610 million aggregate principal amount of fixed rate senior secured notes (the “Notes”).
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.